NIH Requests Public Input on Genetic Testing Registry, Indicates Intent to Include DTC Firms
June 02, 2010
NIH Requests Public Input on Genetic Testing Registry, Indicates Intent to Include DTC Firms
In a request for public input on the scope of its planned voluntary genetic testing registry, NIH indicates that it "anticipates" including tests from direct-to-consumer genomics firms.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- PGen Study to Survey 1K Subjects to Investigate Impact of Personal Genomics Data
March 7, 2012 / Pharmacogenomics Reporter - ACOG Committee Urges Caution for Genetic Testing to Assess Disease Risk
May 30, 2012 / Pharmacogenomics Reporter - NIH Study Finds DTC Genetic Risk Info Doesn't Increase Patients' Use of Healthcare Services
May 23, 2012 / Pharmacogenomics Reporter - Texas Congressman Drafts Bill to Keep Lab Test Oversight out of 'FDA's Lap,' Expand Authority of CMS
October 19, 2011 / Pharmacogenomics Reporter - American Bar Association Passes Resolution on DTC Marketing of Genetic Tests
August 24, 2011 / Pharmacogenomics Reporter